Safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of olamkicept: Results from randomized, placebo-controlled, first-in-human phase I trials.

olamkicept (FE999301) - Ferring

http://www.ncbi.nlm.nih.gov/pubmed/38769747

Ali Falahati; Arjun Ravi; Frank-Dietrich Wagner; Katharina Bruzelius; Ola Sternebring; Philippe Pinton; Stefan Schreiber; Yu Bagger

May 21, 2024